VIOT · Viomi Technology

The thesis

Viomi Technology's ADSs (American depositary shares) have bounced from their late-October low, but the sales recovery is still not in the reported numbers. The next semi-annual results, estimated for around 25 March 2027, must show second-half 2026 revenue above the first-half RMB740.0 million and a return to profit.

Adjusted daily closes show the ADS at $1.90 on 1 October 2026, $1.39 on 28 October 2026 and $1.47 on 10 November 2026. The 52-week high in the current adjusted series is $2.69. The three-month gain is 104.2%, and the 14-day relative strength index (RSI, a 0-100 momentum gauge) is 63.6.

Nasdaq's letter dated 17 September 2026 confirmed that Viomi regained minimum-bid compliance. The story is well known: the listing fix that drove the September rebound is complete, and the only company news since is a 4 November 2026 release on Viomi AI Philippines adding a brand ambassador and a 6 November 2026 announcement of a virtual investor conference appearance. Neither adds a reported sales or profit figure. First-half revenue fell 49.9%, and nothing reported since shows a turn.

Bullish and bearish views on Viomi Technology Co., Ltd

The bull case on Viomi Technology Co., Ltd (VIOT), in brief: cash covers the recovery period. The bear case: sales fell by half.

Bull case

• Cash covers the recovery period. Viomi reported cash and equivalents of RMB603.8 million, translated as US$89.0 million, at 30 June 2026. A further RMB153.3 million of restricted cash is disclosed separately. 27 August 2026 results
• Consumables kept growing. First-half 2026 consumables revenue was RMB131.7 million, up 6.9% year over year, while equipment sales contracted. It was the one segment that grew in the period. 27 August 2026 results
• The listing question is closed for now. Nasdaq confirmed compliance in its 17 September 2026 letter. The close of $1.47 on 10 November 2026 sits above the $1.00 minimum-bid level. Company announcement
• A buyback authorisation remains. The company spent about US$3.8 million on repurchases through 30 June 2026, with US$16.2 million authorised and unspent. 27 August 2026 results
• Southeast Asia marketing is active. A Tribune report dated 29 October 2026 says actress Heart Evangelista was introduced on 28 October 2026 as a Viomi ambassador at a contract-signing event in Parañaque City. The company's own 4 November 2026 release describes the Philippine push. Tribune

Bear case

• Sales fell by half. First-half 2026 revenue declined 49.9% year over year to RMB740.0 million, and the company reported a RMB26.3 million net loss. Management attributed the drop partly to the end of subsidies and called the weakness temporary; that is management's view. 27 August 2026 results
• Financing capacity could dilute holders. A registration statement on Form F-3, amended on 8 September 2026, proposes securities offerings of up to US$100 million. No completed offering is reported. Form F-3/A
• The catalyst that drove the move is spent. The shares rose on the path to minimum-bid compliance. The close then fell from $1.90 on 1 October 2026 to $1.39 on 28 October 2026, and the later recovery to $1.47 on 10 November 2026 came with promotional news only.
• No new financials until spring. As a foreign private issuer, Viomi reports semi-annually, so no sales or profit figure after 30 June 2026 is due until the FY2026 results, estimated for around 25 March 2027.
• Marketing spend precedes proof. Ambassador campaigns in the Philippines add cost, and the company has not reported overseas revenue that shows them paying back.

Price setup

The ADS closed at $1.47 on 10 November 2026, 45.4% below the $2.69 52-week high in the adjusted series. It has risen from the $1.39 close on 28 October 2026. The three-month gain is 104.2% because the window starts before the September compliance rally.

RSI (14-day) is 63.6, up from the 36.7 reading on 28 October 2026. The nearest level that matters for the listing is the $1.00 minimum-bid threshold, which is 32% below the last close by simple subtraction of price from threshold only in the sense that the shares must lose about a third of their value to reach it. The prior low in the recent range is the $1.39 close of 28 October 2026.

Crowding evidence is limited. The note cannot observe real-time insider trades, because Viomi files no Form 4s. The open F-3 registration statement is the main supply risk if the price holds near its recent range.

Catalysts ahead

• Undated, after 6 November 2026: Virtual investor conference appearance announced on 6 November 2026. A management presentation could update the second-half demand outlook, which the first-half results did not resolve.
• Undated, after 8 September 2026: Possible prospectus supplement under the US$100 million registration statement. It would show whether Viomi is issuing shares or ADSs after the price rebound, which would expand the share count.
• ~25 March 2027 (est.): FY2026 and second-half 2026 results, dated from the 25 March 2026 FY2025 release. First scheduled test of whether second-half revenue exceeds the RMB740.0 million first-half level and whether the company returns to profit.

What would change the view

A daily close above $1.90, the highest close of the last 63 sessions (1 October 2026), would show the shares leading the S&P 500 and prove this call wrong.

What it trades with

Viomi trades as a China-based consumer-appliance and water-purifier maker listed in the US, with a small market value and a low share price. Its recent moves have followed company-specific events, mainly the minimum-bid compliance process, rather than a visible sector trend. No current theme in this research set carries the name.